P&K Skin Research Center Co., Ltd. (347740) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for P&K Skin Research Center Co., Ltd. (347740:KRX), powered by AI.

Current Price
₩1,944
P/E Ratio
12.4
Market Cap
58.2B
Sector
Healthcare
What is the P&K Skin Research Center Co., Ltd. stock price forecast?

P&K Skin Research Center Co., Ltd. is currently trading at ₩1,944. View real-time AI analysis on Alpha Lenz.

What is P&K Skin Research Center Co., Ltd. insider trading activity?

View the latest insider trading data for P&K Skin Research Center Co., Ltd. on Alpha Lenz.

What is P&K Skin Research Center Co., Ltd.'s P/E ratio?

P&K Skin Research Center Co., Ltd.'s P/E ratio is 12.4.

P&K Skin Research Center Co., Ltd.

KRX · 347740
₩1,944+4(+0.21%)Market closedKRX regular session 09:00–15:30 KST
Ask about P&K Skin Research Center Co., Ltd.'s future dividend policy...
Alpha Chat Insight

P&K Skin Research Center Co., Ltd. trades at a P/E of 12.4 (undervalued) with modest ROE of 5.9%.

Ask for details

Company Overview

P&K Skin Research Center Co., Ltd. operates as a company specializing in skin science and research. Focused on dermatological studies, the company provides comprehensive testing and analysis services targeted at cosmetic, pharmaceutical, and dermo-cosmetics industries. P&K Skin Research Center is dedicated to advancing the understanding of skin through scientific research methodologies, offering skin efficacy and safety tests, consumer studies, and technology evaluation. Its laboratory and clinical research facilities are equipped to perform a wide range of tests including those for functional cosmetics and skin irritation. In addition to delivering essential data that inform product development and marketing strategies, P&K Skin Research Center contributes significantly to quality assurance and compliance in the skincare and cosmetic sectors. Given the increasing consumer demand for scientifically-backed skincare products, the company's reputable research outcomes help bolster consumer confidence and industry standards.

CEO박진오, 이해광(각자대표)
SectorHealthcare
IndustryDiagnostics & Research
Employees91

Company Statistics

FY 2025

Profile

₩58,220,517,440Market Cap
₩22,783,129,250Revenue
30.01MShares Out
91Employees

Margins

47.02%Gross
38.44%EBITDA
17.29%Operating
25.24%Pre-Tax
20.21%Net

Valuation

12.43P/E
0.72P/B
2.56EV/Sales
6.30EV/EBITDA
11.25P/FCF

Growth (CAGR)

8.26%Rev 3Yr
9.19%Rev 5Yr
-11.27%Op Inc 3Yr
-11.40%Op Inc 5Yr
-13.57%Net Inc 3Yr
-7.28%Net Inc 5Yr

Returns

5.46%ROA
5.95%ROE
6.88%ROIC

Financial Health

₩3,968,374,450Cash & Cash Equivalents
₩2,073,614,930Net Debt
7.51%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

P&K Skin Research Center Co., Ltd. (ticker: 347740) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 91 employees. Market cap is $58.2B.

The current price is ₩1,944 with a P/E ratio of 12.43x and P/B of 0.72x.

ROE is 5.95% and operating margin is 17.29%. Annual revenue is $22.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
P&K Skin Research Center Co., Ltd. (347740) Stock Forecast 2026 ₩1,944 — Price, Financials & Analyst Targets | Alpha Lenz